Future Market Insights, Inc.’s latest market projection forecasts a 6.0% growth for the global construction anchor market from 2024 to 2034. This report unveils key trends shaping the industry and highlighting opportunities for stakeholders. NEWARK, Del., Feb. 7, 2024 /PRNewswire/ — The global construction anchor market is anticipated to exhibit robust growth, expanding from US$13.87 billion… Continue reading Construction Anchor Market to Witness 6.0% Growth by 2034, Fueled by Chemical Anchor Demand
Category: Newswire
Huawei объявляет о расширении своей программы развития талантов в Риме этим летом
Объявление было сделано на закрытии европейского раунда в Китае, длившегося неделю ПЕКИН, 8 февраля 2024 г. /PRNewswire/ — Европейский гранд-финал программы «Seeds for the future European Grand Finale», собравший под свои крылом группу лучших выпускников программы «Seeds for the Future» из 18 европейских стран, завершился 23 января. За эту неделю выпускники приняли участие в увлекательных… Continue reading Huawei объявляет о расширении своей программы развития талантов в Риме этим летом
ALIMENTATION COUCHE-TARD INC. PRICES PRIVATE OFFERINGS OF US$ AND € DENOMINATED SENIOR UNSECURED NOTES
LAVAL, QC, Feb. 7, 2024 /PRNewswire/ – Alimentation Couche-Tard Inc. (“Couche-Tard” or the “Corporation”) (TSX: ATD) announced today that it has priced a private debt offering of US dollar denominated senior unsecured notes with an aggregate principal amount of US$1.5B, consisting of two tranches of notes (the “US$ Notes”), and that it has priced a… Continue reading ALIMENTATION COUCHE-TARD INC. PRICES PRIVATE OFFERINGS OF US$ AND € DENOMINATED SENIOR UNSECURED NOTES
Huawei erweitert in diesem Sommer sein Talententwicklungsprogramm in Rom
Ankündigung erfolgte zum Abschluss einer einwöchigen europäischen Veranstaltung in China BEIJING, 7. Februar 2024 /PRNewswire/ — Am 23. Januar endete ein einwöchiges „Seeds for the future European Grand Finale”, das eine ausgewählte Gruppe von „Seeds for the Future”-Absolventen aus 18 europäischen Ländern zusammenbrachte. Während der gesamten Woche nahmen die Teilnehmer an aufschlussreichen Sitzungen mit Technikexperten teil,… Continue reading Huawei erweitert in diesem Sommer sein Talententwicklungsprogramm in Rom
Sun Life declares dividends on Common and Preferred Shares payable in Q1 2024
TORONTO, Feb. 7, 2024 /PRNewswire/ – The Board of Directors (the “Board”) of Sun Life Financial Inc. (the “Company”) (TSX: SLF) (NYSE: SLF) today announced that a dividend of $0.78 per share on the common shares of the Company has been declared, payable March 28, 2024 to shareholders of record at the close of business… Continue reading Sun Life declares dividends on Common and Preferred Shares payable in Q1 2024
Sun Life Reports Fourth Quarter and Full Year 2023 Results
The information in this document is based on the unaudited interim financial results of Sun Life Financial Inc. (“SLF Inc.”) for the period ended December 31, 2023. SLF Inc., its subsidiaries and, where applicable, its joint ventures and associates are collectively referred to as “the Company”, “Sun Life”, “we”, “our”, and “us”. We manage our operations… Continue reading Sun Life Reports Fourth Quarter and Full Year 2023 Results
AANA Emphasizes Access to Safe Dental Anesthesia Care in Recognition of National Children’s Dental Health Month
ROSEMONT, Ill., Feb. 7, 2024 /PRNewswire/ — (AANA) – February is National Children’s Dental Health Month, and the American Association of Nurse Anesthesiology (AANA) reminds parents and caregivers of the importance of not only knowing how to keep your child’s teeth healthy, but also ensuring that they have access to safe dental anesthesia care. This month-long… Continue reading AANA Emphasizes Access to Safe Dental Anesthesia Care in Recognition of National Children’s Dental Health Month
Investigational targeted oral peptide JNJ-2113 demonstrated positive results in moderate-to-severe plaque psoriasis in Phase 2b study published in New England Journal of Medicine
Data from FRONTIER 1, a Phase 2b clinical trial, show JNJ-2113, the first and only targeted oral peptide that selectively blocks the IL-23 receptor, achieved the primary and all secondary endpoints including PASIa 100 and IGAb 0 responses of 40.5 percent and 45.2 percent, respectively SPRING HOUSE, Penn., Feb. 7, 2024 /PRNewswire/ — Johnson &… Continue reading Investigational targeted oral peptide JNJ-2113 demonstrated positive results in moderate-to-severe plaque psoriasis in Phase 2b study published in New England Journal of Medicine
GMGI Appoints Dr. Andrew Gardner as Inaugural Chief Scientific Officer
GLOUCESTER, Mass., Feb. 7, 2024 /PRNewswire/ — Gloucester Marine Genomics Institute (GMGI), a 501c3 non-profit addressing critical challenges facing our oceans, human health, and the environment through innovative scientific research and education, announced the appointment of Dr. Andrew Gardner as the organization’s inaugural Chief Scientific Officer (CSO). Dr. Gardner brings an impressive track record of discovery,… Continue reading GMGI Appoints Dr. Andrew Gardner as Inaugural Chief Scientific Officer
Blue Owl Capital to Partner with Lunate to Invest in Private Market Investment Managers
Partnership will target mid-sized private market managers NEW YORK and ABU DHABI, UAE, Feb. 7, 2024 /PRNewswire/ — Blue Owl Capital Inc. (“Blue Owl”) (NYSE: OWL), a leading alternative asset manager, and Lunate, a global alternative investment manager headquartered in Abu Dhabi, managing US$105 billion in assets, announced today a joint venture to provide growth capital to leading… Continue reading Blue Owl Capital to Partner with Lunate to Invest in Private Market Investment Managers